These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. From understanding synaptic plasticity to the development of cognitive enhancers. Cheung ZH; Ip NY Int J Neuropsychopharmacol; 2011 Oct; 14(9):1247-56. PubMed ID: 21208502 [TBL] [Abstract][Full Text] [Related]
27. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases. Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298 [TBL] [Abstract][Full Text] [Related]
28. Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases. Herrera-Arozamena C; Martí-Marí O; Estrada M; de la Fuente Revenga M; Rodríguez-Franco MI Molecules; 2016 Sep; 21(9):. PubMed ID: 27598108 [TBL] [Abstract][Full Text] [Related]
29. Cytoskeletal protection: acting on notch to prevent neuronal dysfunction. Bonini SA; Ferrari-Toninelli G; Maccarinelli G; Bettinsoli P; Montinaro M; Memo M Neurodegener Dis; 2014; 13(2-3):93-5. PubMed ID: 24008813 [TBL] [Abstract][Full Text] [Related]
30. The adiponectin signaling pathway as a novel pharmacological target. Mao X; Hong JY; Dong LQ Mini Rev Med Chem; 2006 Dec; 6(12):1331-40. PubMed ID: 17168809 [TBL] [Abstract][Full Text] [Related]
31. Emerging Concepts and Functions of Autophagy as a Regulator of Synaptic Components and Plasticity. Liang Y Cells; 2019 Jan; 8(1):. PubMed ID: 30634508 [TBL] [Abstract][Full Text] [Related]
32. Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders. Carvalho IM; Coelho PB; Costa PC; Marques CS; Oliveira RS; Ferreira DC Neuromolecular Med; 2015 Dec; 17(4):404-22. PubMed ID: 26374113 [TBL] [Abstract][Full Text] [Related]
33. Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration. Ganai SA; Ramadoss M; Mahadevan V Curr Neuropharmacol; 2016; 14(1):55-71. PubMed ID: 26487502 [TBL] [Abstract][Full Text] [Related]
36. The Dysregulation of microRNAs and the Role of Stress in the Pathogenesis of Mental Disorders. Ivanova E; Bozhilova R; Kaneva R; Milanova V Curr Top Med Chem; 2018; 18(21):1893-1907. PubMed ID: 30499408 [TBL] [Abstract][Full Text] [Related]
37. Psychiatric aspects of phosphodiesterases: An overview. Murthy VS; Mangot AG Indian J Pharmacol; 2015; 47(6):594-9. PubMed ID: 26729948 [TBL] [Abstract][Full Text] [Related]
38. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Knuesel I Prog Neurobiol; 2010 Aug; 91(4):257-74. PubMed ID: 20417248 [TBL] [Abstract][Full Text] [Related]
39. P2X7 receptor: an emerging target in central nervous system diseases. Sperlágh B; Illes P Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574 [TBL] [Abstract][Full Text] [Related]
40. Physical exercise and mitochondrial function: New therapeutic interventions for psychiatric and neurodegenerative disorders. Sun L; Liu T; Liu J; Gao C; Zhang X Front Neurol; 2022; 13():929781. PubMed ID: 36158946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]